A team of scientists in NCI at Frederick’s Center for Cancer Research Mouse Cancer Genetics Program and their collaborators at the University of Florence have identified a link between the presence of a growth factor receptor and cognitive impairments in patients with amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease).

The future of the Frederick National Laboratory (FNL) and its large initiatives was at the forefront of the recent Frederick National Laboratory Advisory Committee (FNLAC) meeting held in Shady Grove. Here are a few excerpts, accompanied by time stamps from the videocast.

Employees crowded into the Building 549 auditorium as Norman E. Sharpless, M.D., took the podium at Shady Grove, addressing NCI and contractor employees watching live and via telecast viewings. “What a difference a year makes,” he began, reflecting on how he was sworn in on the same day exactly one year ago.

Staff at NCI at Frederick will be able to participate in the Fall 2018 NCI Staff Town Hall on Wednesday, October 17, from 10:30–11:30 a.m., which will be videocast live to the Building 549 auditorium. NCI Director Norman E. “Ned” Sharpless is hosting the town hall at NCI at Shady Grove, his second since becoming director in October 2017, and is expected to speak about his plans for NCI.

Each year at NCI at Frederick, high school student interns stand shoulder to shoulder with their undergraduate and graduate-school colleagues to share posters about their scientific research and enhance their communication and networking skills.